Teva Pharmaceutical Industries Limited (TEVA)

Health Care > Major Pharmaceuticals

Price

  • Last Close
  • $ 9.45
    -0.58
  • Trading Volume
  • 16,426,893
  • Market Cap
  • $ 11.1B
  • 52-Week High/Low
  • 12.81 - $8.31

Earnings

  • Earning
  • 2020 2021
    $ -3.64 -
  • 2021 P/E Ratio
  • Trailing Forward
    -2.78 -
  • Short share
  • Date Shares Ratio
    Sep 30, 2019 79280628 7.26

Gain

  • 30-day
  • TEVA 13.18%
    S&P 500 3.25%
  • 90-day
  • 13.95%
  • 3.62%
  • 180-day
  • -2.31%
  • 9.81%
  • 52-Week
  • 7.88%
  • 35.3%

Dividend

  • Dividend
  • 0
  • Dividend Yield
  • ;0%
  • Outstanding
  • 1,091,600,000
  • 50 Day Avg Volume
  • 63705972

Calender

  • Fiscal Year End
  • Dec 31
  • Last Earning Date
  • Dec 31, 1969
  • Ex-Dividend Date
  • Nov 27, 2017
  • Current Year Beta
  • 0.7

Ratio

  • Debt To EQuity
  • 1.69
  • Return On Equity
  • -15.19%
  • Book Value
  • $10.1

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Q1 0.1 0.1 -0.1 1 1 1.2 1.4 0.9 0.7 1 0.8 0.8
Q2 0.2 0.1 -0.6 -0.2 1 1.3 1.4 0.9 -0.5 1 0.6 0.9
Q3 0 -4 -0.3 -0.3 1 1.3 1.4 1 0.8 -0.1 1 1.2
Q4 0 0.1 0.1 -2.9 0.9 1.4 1.3 0.8 0.4 0.4 0.6 0.9
A 0.3 -3.6 -0.9 -2.4 3.9 5.1 5.4 3.6 1.5 2.3 3.1 3.7

Dividend
+

2016 2017
Q1 0.34 0.34
Q2 0.34 0.34
Q3 0.34 0.085
Q4 0.34 0.085
A 1.36 0.85

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 19.6% -10% 1.7% -9.8% -10.6% -18% 9% 32.8% 7.1% 12.3% -
Q2 -14.2% 37.3% -41.4% 45% 4.8% -5.5% -4.6% -0.1% -0.1% -12.9% -
Q3 -1.6% -26.9% -27.1% -12% -46.7% -7.8% -4% 3.2% -2.4% 6.2% -
Q4 4% 7.1% 47.3% -28.2% 3.2% -20.5% 16.9% 7.6% 7% -8.6% -

Returns +
M

J F M A M J J A S O N D
2021 22.1% -8.7% 7.3% -7.3% -2.8% -4.8% -2.8% -2.1% 3.4% -3% - -
2020 4.2% 10.9% -22.1% 19.6% 16.7% -1.6% -6.4% -14.5% -8.7% -3.2% 10.6% 0.1%

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
TEVA -2%-3%-35%-19%-46%-43%17%47%11%-5%-21%

Annual
Returns

52 Week
High/Low

Earnings

Chart